Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment

作者: Goodarz Danaei , Carlene MM Lawes , Stephen Vander Hoorn , Christopher JL Murray , Majid Ezzati

DOI: 10.1016/S0140-6736(06)69700-6

关键词:

摘要: Summary Background Cardiovascular mortality risk increases continuously with blood glucose, from concentrations well below conventional thresholds used to define diabetes. We aimed quantify population-level effects of all higher-than-optimum glucose on ischaemic heart disease and stroke worldwide. Methods population distribution fasting plasma measure exposure glucose. collated data in 52 countries individual-level records health surveys, systematic reviews, provided by investigators. Relative risks for were a meta-analysis more than 200 000 participants the Asia-Pacific region, adjustment other cardiovascular factors. Results In addition 959 000 deaths directly assigned diabetes, 1 490 000 709 000 attributable high accounting 21% 13% these conditions. 1·8 million 2·2 (84%) low-and-middle-income (1 224 000 disease, 623 000 stroke). 792 000 (53%) 345 000 (49%) that men. Largest numbers this factor South Asia (548 000) Europe Central (313 000), (215 000) East Pacific (190 000). Interpretation Higher-than-optimum is leading cause most world regions. Programmes diabetes management control at level need be closely integrated.

参考文章(45)
UK Prospective Diabetes Study Group, None, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ. ,vol. 317, pp. 703- 713 ,(1998)
L. TOMÁS-ABADAL, C. VARAS-LORENZO, E. BERNADES-BERNAT, I. BALAGUER-VINTRÓ, Coronary risk factors and a 20-year incidence of coronary heart disease and mortality in a Mediterranean industrial population : the Manresa study, Spain European Heart Journal. ,vol. 15, pp. 1028- 1036 ,(1994) , 10.1093/OXFORDJOURNALS.EURHEARTJ.A060624
Lindström J, Eriksson J, Qiao Q, Jousilahti P, Tuomilehto J, Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies ,(1999)
Majid Ezzati, Stephen Vander Hoorn, Alan D. Lopez, Christopher J. L. Murray, Alan D. Rodgers, Estimating attributable burden of disease from exposure and hazard data World Health Organization. ,vol. 2, pp. 2129- 2140 ,(2004)
James B Meigs, David M Nathan, Ralph B D’Agostino Sr, Peter WF Wilson, None, Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care. ,vol. 25, pp. 1845- 1850 ,(2002) , 10.2337/DIACARE.25.10.1845
H. C. Gerstein, Is glucose a continuous risk factor for cardiovascular mortality Diabetes Care. ,vol. 22, pp. 659- 660 ,(1999) , 10.2337/DIACARE.22.5.659
Global burden of disease and risk factors World Bank Publications. pp. 1- 506 ,(2006) , 10.1596/978-0-8213-6262-4
K. Miedema, Towards worldwide standardisation of HbA1c determination. Diabetologia. ,vol. 47, pp. 1143- 1148 ,(2004) , 10.1007/S00125-004-1453-0